Correlation Between Immix Biopharma and Avantor

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Avantor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Avantor into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Avantor, you can compare the effects of market volatilities on Immix Biopharma and Avantor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Avantor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Avantor.

Diversification Opportunities for Immix Biopharma and Avantor

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Immix and Avantor is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Avantor in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avantor and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Avantor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avantor has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Avantor go up and down completely randomly.

Pair Corralation between Immix Biopharma and Avantor

Given the investment horizon of 90 days Immix Biopharma is expected to under-perform the Avantor. In addition to that, Immix Biopharma is 2.92 times more volatile than Avantor. It trades about 0.0 of its total potential returns per unit of risk. Avantor is currently generating about 0.0 per unit of volatility. If you would invest  2,368  in Avantor on November 3, 2024 and sell it today you would lose (140.00) from holding Avantor or give up 5.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Immix Biopharma  vs.  Avantor

 Performance 
       Timeline  
Immix Biopharma 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Immix Biopharma are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Immix Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.
Avantor 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avantor has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Avantor is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Immix Biopharma and Avantor Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Immix Biopharma and Avantor

The main advantage of trading using opposite Immix Biopharma and Avantor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Avantor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avantor will offset losses from the drop in Avantor's long position.
The idea behind Immix Biopharma and Avantor pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios